Time to reconsider risk stratification in dilated cardiomyopathy

Código QR

Time to reconsider risk stratification in dilated cardiomyopathy

Guardado en:

Detalles Bibliográficos
Autores principales:	A. Laina, K.A. Gatzoulis, S. Soulaidopoulos, P. Arsenos, I. Doundoulakis, D. Tsiachris, S. Sideris, A. Kordalis, D. Tousoulis, K. Tsioufis
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/a5b3d8c2fa7341098b1c057f44c7acf7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Ryan Wallace, et al.
Publicado: (2021)

Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early?
por: Maki Komiyama, et al.
Publicado: (2020)

The Role of Cardiac MRI in the Management of Ventricular Arrhythmias in Ischaemic and Non-ischaemic Dilated Cardiomyopathy
por: Tom Nelson, et al.
Publicado: (2019)

Left ventricular torsion an echocardiographic prognosticator in dilated cardiomyopathy patients
por: Amit Kumar, et al.
Publicado: (2021)

Early Death of 2 Siblings Related to Mutations in LMOD2, a Recently Discovered Cause of Neonatal Dilated Cardiomyopathy
por: Steven C. Greenway, MSc, MD, FRCPC, et al.
Publicado: (2021)

Right ventricular pacing-induced cardiomyopathy: Is there a role for blood biomarkers?
por: Dimitris Tousoulis, et al.
Publicado: (2021)

Risk stratification of women with peripartum cardiomyopathy at initial presentation: A dobutamine stress echocardiography study
por: R. Archana Resident, et al.
Publicado: (2021)

Myocardial mechanics in dilated cardiomyopathy: prognostic value of left ventricular torsion and strain
por: Andreas Ochs, et al.
Publicado: (2021)

Cardiac Resynchronisation Therapy and Cellular Bioenergetics: Effects Beyond Chamber Mechanics
por: Christos-Konstantinos Antoniou, et al.
Publicado: (2019)

Insights for Stratification of Risk in Brugada Syndrome
por: Daniel García Iglesias, et al.
Publicado: (2019)

Stiff to Dilate and Risky to Cut Through: Iliac Radiation Arteritis
por: Huthayfa Ghanem, et al.
Publicado: (2020)

Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
por: Nancy Luo, MD, MHS, et al.
Publicado: (2021)

Brugada Syndrome: Progress in Genetics, Risk Stratification and Management
por: Jorge Romero, et al.
Publicado: (2019)

Diabetic Cardiomyopathy: Five Major Questions with Simple Answers
por: Miguel Alejandro Rodriguez-Ramos
Publicado: (2019)

Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype?
por: Alexandros Protonotarios, et al.
Publicado: (2020)

Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
por: J Gustav Smith, et al.
Publicado: (2021)

A new biomarker that predicts ventricular arrhythmia in patients with ischemic dilated cardiomyopathy: Galectin-3
por: Onur Erdogan, et al.
Publicado: (2021)

A new biomarker that predicts ventricular arrhythmia in patients with ischemic dilated cardiomyopathy: Galectin-3
por: Onur Erdogan, et al.
Publicado: (2021)

The Role of C-reactive Protein in Patient Risk Stratification and Treatment
por: Ramón Arroyo-Espliguero, et al.
Publicado: (2021)

Utility of Blood Cellular Indices in the Risk Stratification of Patients Presenting with Acute Pulmonary Embolism
por: Brett Slajus MPH, et al.
Publicado: (2021)

Pre-dilation and Post-dilation in Transcatheter Aortic Valve Replacement: Indications, Benefits and Risks
por: Angela McInerney, et al.
Publicado: (2021)

Sacubitril/valsartan alleviates myocardial fibrosis in diabetic cardiomyopathy rats
por: Jiao Ai, et al.
Publicado: (2021)

Restrictive cardiomyopathy with ring chromosome 6 anomaly in a child
por: Süleyman Sunkak, et al.
Publicado: (2021)

Rate of Heart Failure Following Atrial Fibrillation According to Presence of Family History of Dilated Cardiomyopathy or Heart Failure: A Nationwide Study
por: Magnus N. Ebbesen, et al.
Publicado: (2021)

From Hip to Heart: A Comprehensive Evaluation of an Infiltrative CardiomyopathyNovel Teaching Points
por: Manavotam Singh, MD, et al.
Publicado: (2021)

Association of ADRB2 gene polymorphism with dilated cardiomyopathy
por: Svetlana Y. Nikulina, et al.
Publicado: (2021)

Erratum to “The atrial switch patient with a dilated subpulmonic left ventricle” [Int. J. Cardiol. Congenit. Heart Dis. 4 (August 2021) 100153]
por: Sumeet S. Vaikunth, et al.
Publicado: (2021)

Multimodality Imaging to Guide Ventricular Tachycardia Ablation in Patients with Non-ischaemic Cardiomyopathy
por: Ling Kuo, et al.
Publicado: (2020)

Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients
por: Jiang Li, et al.
Publicado: (2021)

Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Roland R Tilz, et al.
Publicado: (2019)

Sudden Cardiac Death Risk Stratification and Prevention in Chagas Disease: A Non-systematic Review of the Literature
por: Roberto Keegan, et al.
Publicado: (2020)

Transcatheter Aortic Valve Implantation and Subclinical and Clinical Leaflet Thrombosis: Multimodality Imaging for Diagnosis and Risk Stratification
por: María Martín, et al.
Publicado: (2021)

Association Between Left Ventricular Global Function Index and Outcomes in Patients With Dilated Cardiomyopathy
por: Tong Liu, et al.
Publicado: (2021)

Corrigendum to: Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Roland R Tilz, et al.
Publicado: (2020)

Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy
por: Sarinya Puwanant, et al.
Publicado: (2021)

Deep Learning Predicts Heart Failure With Preserved, Mid-Range, and Reduced Left Ventricular Ejection Fraction From Patient Clinical Profiles
por: Mohanad Alkhodari, et al.
Publicado: (2021)

Comorbidity Differentiation and Risk Stratification in the Elderly Patient with Polypharmacy: A Prospective Primary Care Registry on Oral Anticoagulation Therapy
por: S van Vugt, et al.
Publicado: (2020)

Persistent left vertical vein: An unusual cause of pulmonary hypertension and cirrhosis in a patient with hypertrophic obstructive cardiomyopathy
por: Umut Karabulut, et al.
Publicado: (2021)

Severe right ventricular hypertrophy in hypertrophic cardiomyopathy: Serious symptoms, complex surgical procedures, and poor prognosis in Fuwai Hospital
por: Xueqi Dong, et al.
Publicado: (2021)

Prognostic Significance of Feature-Tracking Right Ventricular Global Longitudinal Strain in Non-ischemic Dilated Cardiomyopathy
por: Marco Cittar, et al.
Publicado: (2021)